Squarepoint’s Rocket Pharmaceuticals RCKT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$470K Buy
192,018
+138,542
+259% +$339K ﹤0.01% 1941
2025
Q1
$357K Buy
+53,476
New +$357K ﹤0.01% 2102
2024
Q4
Sell
-53,039
Closed -$980K 3138
2024
Q3
$980K Buy
+53,039
New +$980K ﹤0.01% 1452
2024
Q2
Sell
-27,229
Closed -$734K 2885
2024
Q1
$734K Buy
27,229
+769
+3% +$20.7K ﹤0.01% 1492
2023
Q4
$793K Sell
26,460
-20,688
-44% -$620K ﹤0.01% 1467
2023
Q3
$966K Buy
47,148
+30,587
+185% +$627K ﹤0.01% 1317
2023
Q2
$329K Buy
+16,561
New +$329K ﹤0.01% 1825
2023
Q1
Sell
-12,201
Closed -$239K 2685
2022
Q4
$239K Sell
12,201
-11,674
-49% -$228K ﹤0.01% 1803
2022
Q3
$381K Buy
+23,875
New +$381K ﹤0.01% 1511
2022
Q2
Sell
-28,056
Closed -$445K 2534
2022
Q1
$445K Sell
28,056
-13,715
-33% -$218K ﹤0.01% 1551
2021
Q4
$912K Buy
+41,771
New +$912K ﹤0.01% 1270
2021
Q2
Sell
-18,923
Closed -$840K 2958
2021
Q1
$840K Sell
18,923
-2,087
-10% -$92.6K ﹤0.01% 1206
2020
Q4
$1.15M Sell
21,010
-11,878
-36% -$651K 0.01% 993
2020
Q3
$752K Sell
32,888
-24,827
-43% -$568K 0.01% 1092
2020
Q2
$1.21M Buy
+57,715
New +$1.21M 0.02% 835
2020
Q1
Sell
-19,262
Closed -$438K 2330
2019
Q4
$438K Sell
19,262
-15,316
-44% -$348K ﹤0.01% 1796
2019
Q3
$403K Sell
34,578
-4,286
-11% -$50K ﹤0.01% 1669
2019
Q2
$583K Buy
38,864
+5,008
+15% +$75.1K 0.01% 1546
2019
Q1
$594K Sell
33,856
-13,563
-29% -$238K 0.01% 1379
2018
Q4
$703K Buy
47,419
+36,219
+323% +$537K 0.01% 1058
2018
Q3
$276K Buy
+11,200
New +$276K ﹤0.01% 1577
2017
Q4
Sell
-31,741
Closed -$226K 2287
2017
Q3
$226K Buy
31,741
+28,022
+753% +$200K ﹤0.01% 1312
2017
Q2
$28K Buy
+3,719
New +$28K ﹤0.01% 1472
2017
Q1
Sell
-3,795
Closed -$93K 1841
2016
Q4
$93K Buy
+3,795
New +$93K ﹤0.01% 1632